Literature DB >> 35911664

ZEB1 induces N-cadherin expression in human glioblastoma and may alter patient survival.

Hanna Gött1, Jasmin Nagl1, Frederike Hagedorn2, Samuel Thomas1, Frank P Schwarm1, Eberhard Uhl1, Malgorzata A Kolodziej1.   

Abstract

The present study investigated the expression of epithelial-mesenchymal transition (EMT)-related factors zinc finger E-box-binding homeobox 1 (ZEB1), cadherin-1 (CDH1), cadherin-2 (CDH2) and the cell cycle modulating kinase cyclin-dependent kinase 1 (CDK1) in human glioblastoma (GBM) compared to normal brain tissue, as well as whether the levels of expression were associated with the overall and progression-free survival of the GBM patients. In 44 GBM and five normal brain tissue specimens, the expression levels of ZEB1, CDH1, CDH2 and CDK1 were evaluated by real-time PCR and immunostaining, and the results were correlated with clinical data. The expression levels of all investigated genes as detected by immunostaining were significantly higher in the GBM when compared to the normal brain tissues. There was no influence on survival. A linear correlation between ZEB1 and CDH2 and CDK1 expression was observed in GBM. Moreover, ZEB1 was involved in EMT (e.g., signaling in human GBM) and high ZEB1 levels were linked to an aberrant cell cycle processing, marked by CDK1 overexpression.
Copyright © 2020, Spandidos Publications.

Entities:  

Keywords:  CDK1; ZEB1; cancer; cell cycle; epithelial to mesenchymal transition; gene expression; glioblastoma; molecular oncology; tumor progression

Year:  2022        PMID: 35911664      PMCID: PMC9326511          DOI: 10.3892/mco.2022.2556

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  35 in total

1.  N-cadherin expression level modulates integrin-mediated polarity and strongly impacts on the speed and directionality of glial cell migration.

Authors:  Emeline Camand; Florent Peglion; Naël Osmani; Marc Sanson; Sandrine Etienne-Manneville
Journal:  J Cell Sci       Date:  2012-01-24       Impact factor: 5.285

Review 2.  Malignant glioma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Authors:  R Stupp; F Roila
Journal:  Ann Oncol       Date:  2009-05       Impact factor: 32.976

Review 3.  The role of the ZEB family of transcription factors in development and disease.

Authors:  C Vandewalle; F Van Roy; G Berx
Journal:  Cell Mol Life Sci       Date:  2009-03       Impact factor: 9.261

4.  DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells.

Authors:  Andreas Eger; Kirsten Aigner; Stefan Sonderegger; Brigitta Dampier; Susanne Oehler; Martin Schreiber; Geert Berx; Amparo Cano; Hartmut Beug; Roland Foisner
Journal:  Oncogene       Date:  2005-03-31       Impact factor: 9.867

5.  E-Cadherin in human brain tumours: loss of immunoreactivity in malignant meningiomas.

Authors:  K Schwechheimer; L Zhou; W Birchmeier
Journal:  Virchows Arch       Date:  1998-02       Impact factor: 4.064

6.  Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas.

Authors:  Satoshi Utsuki; Yuichi Sato; Hidehiro Oka; Benio Tsuchiya; Sachio Suzuki; Kiyotaka Fujii
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

7.  [CDK1 expression and effects of CDK1 silencing on the malignant phenotype of glioma cells].

Authors:  Hua Chen; Qiang Huang; De-zhong Zhai; Jun Dong; Ai-dong Wang; Qing Lan
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2007-07

Review 8.  The epithelial-mesenchymal transition: new insights in signaling, development, and disease.

Authors:  Jonathan M Lee; Shoukat Dedhar; Raghu Kalluri; Erik W Thompson
Journal:  J Cell Biol       Date:  2006-03-27       Impact factor: 10.539

9.  ZEB1 regulates glioma stemness through LIF repression.

Authors:  Lincoln A Edwards; Aiguo Li; Dror Berel; Mecca Madany; Nam-Ho Kim; Minzhi Liu; Mitch Hymowitz; Benjamin Uy; Rachel Jung; Minlin Xu; Keith L Black; Altan Rentsendorj; Xuemo Fan; Wei Zhang; John S Yu
Journal:  Sci Rep       Date:  2017-02-28       Impact factor: 4.379

Review 10.  Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.

Authors:  Bowen Du; Joong Sup Shim
Journal:  Molecules       Date:  2016-07-22       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.